We first assessed whether the expression of MIAT was altered in atherosclerotic disease using quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis of serum RNA extracted from the control group and atherosclerotic patients who had suffered either a transient ischemic attack or stroke (symptomatic) or were asymptomatic. The gene discussed is MIAT; the disease is Stroke.